\-\ Texto\\:\\ \ \(0\)\
\-\ pcr\\ of\\ csf\\:\ \(0\)\
\-\ hsv\\ 1\\ dna\\â\\€\\¦\\.\\.detected\ \(0\)\
\-\ hsv\\ 2\\ dna\\â\\€\\¦\\.\\.not\\ detected\ \(0\)\
\-\ csf\\:\ \(0\)\
\-\ glucose\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ \\ 115\\.0\\ \\ \\ \\ \\ h\\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\(40\\-70\\)\\ \\ \\ \\ \\ \\ \\ \\ mg\\/dl\ \(0\)\
\-\ protein\\ csf\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ \\ 150\\ \\ \\ \\ \\ \\ \\ h\\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\(12\\-60\\)\\ \\ \\ \\ \\ \\ \\ \\ mg\\/dl\ \(0\)\
\-\ color\\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ \\ colorless\\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \ \(0\)\
\-\ appear\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ \\ clear\\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \ \(0\)\
\-\ wbc\\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ \\ 259\\ \\ \\ \\ \\ \\ \\ h\\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\(0\\.0\\-5\\.0\\)\\ \\ \\ \\ \\ \\ \\ cu\\/mm\ \(0\)\
\-\ rbc\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ 133\\ \\ \\ \\ \\ h\\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\(0\\-1\\)\\ \\ \\ \\ \\ \\ \\ \\ \\ cu\\/mm\ \(0\)\
\-\ lymph\\.\\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ 99\\ \\ \\ \\ \\ \\ \\ h\\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\(40\\-80\\)\\ \\ \\ \\ \\ \\ \\ \\ \\%\ \(0\)\
\-\ mono\\ \\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\.\\ \\ \\ 1\\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\%\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ \ \(1250\)\
\-\ serum\\ wbc\\:\\ 11\\.2\ \(0\)\
\-\ intravenous\\ acyclovir\\.\ \(1\)\
\-\ non\\-contrast\\ ct\\:\\ hypoattenuation\\ in\\ the\\ left\\ temporal\\ and\\ inferior\\ frontal\\ lobes\\.\\ \\ mild\\ mass\\ effect\\ is\\ also\\ seen\\ with\\ effacement\\ of\\ the\\ sylvian\\ cistern\\,\\ and\\ ambient\\ cistern\\.\ \(0\)\
\-\ contrast\\ enhanced\\ ct\\:\\ \\ patchy\\ peripheral\\ enhancement\\ in\\ the\\ bilateral\\ temporal\\ lobes\\,\\ and\\ insula\\.\\ \\ there\\ are\\ also\\ foci\\ of\\ circumscribed\\ low\\ density\\ within\\ the\\ left\\ insula\\,\\ and\\ evidence\\ of\\ subtle\\ mass\\ effect\\.\ \(0\)\
\-\ mri\\:\ \(0\)\
\-\ dwi\\:\\ t2\\ signal\\ hyperintensity\\ with\\ restricted\\ diffusion\\,\\ in\\ the\\ left\\ temporal\\ lobe\\,\\ and\\ bilateral\\ insula\\.\ \(0\)\
\-\ t2wi\\:\\ increased\\ signal\\ intensity\\ and\\ swelling\\ of\\ the\\ gray\\ matter\\ of\\ the\\ left\\ temporal\\ lobe\\ with\\ mild\\ mass\\ effect\\,\\ evidenced\\ by\\ effacement\\ of\\ the\\ ambient\\ cistern\\ at\\ the\\ left\\ medial\\ temporal\\ lobe\\ and\\ midbrain\\.\\ \\ additionally\\,\\ there\\ is\\ mild\\ increased\\ signal\\ intensity\\ of\\ the\\ right\\ medial\\ temporal\\ lobe\\.\\ \\ also\\,\\ there\\ is\\ increased\\ signal\\ intensity\\ in\\ the\\ left\\ greater\\ than\\ right\\ insular\\ gray\\ matter\\.\ \(0\)\
\-\ coronal\\ t2\\-weighted\\ flair\\ mr\\ shows\\ bilateral\\ asymmetric\\ involvement\\ of\\ the\\ medial\\ temporal\\ lobes\\ and\\ insula\\.\ \(0\)\
\-\ \\ \ \(1082074\)\
\-\ t1wi\\:\\ \\ low\\ signal\\ intensity\\ in\\ the\\ left\\ greater\\ than\\ right\\ insula\\ secondary\\ to\\ surrounding\\ edema\\,\\ with\\ no\\ evidence\\ of\\ hyperintensity\\ to\\ suggest\\ the\\ presence\\ of\\ subacute\\ blood\\ products\\.\\ \\ \ \(0\)\
\-\ post\\-gadolinium\\ t1wi\\ demonstrates\\ patchy\\ peripheral\\ enhancement\\ in\\ the\\ left\\ temporal\\ lobe\\,\\ and\\ left\\ greater\\ than\\ right\\ insula\\.\ \(0\)\
\-\ herpes\\ encephalitis\\ hsv\\-1\ \(0\)\
\-\ hsv\\ encephalitis\ \(0\)\
\-\ ischemia\ \(171\)\
\-\ infiltrating\\ neoplasm\ \(3\)\
\-\ status\\ epilepticus\ \(3\)\
\-\ abscess\ \(594\)\
\-\ other\\ encephalitides\\ \\(neurosyphilis\\)\ \(0\)\
\-\ 21\\ yo\\ male\\ presenting\\ with\\ fever\\,\\ new\\ onset\\ of\\ aphasia\\,\\ and\\ one\\ episode\\ of\\ loss\\ of\\ consciousness\\.\ \(1\)\
\-\ the\\ prognosis\\ of\\ this\\ patient\\ is\\ very\\ poor\\,\\ as\\ he\\ presented\\ with\\ aphasia\\,\\ and\\ one\\ episode\\ of\\ loss\\ of\\ consciousness\\ before\\ receiving\\ intravenous\\ acyclovir\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ insula\\:\\ 0\\.09857673486273165\ \(0\)\
\-\ temporal\\:\\ 0\\.06676860249003194\ \(0\)\
\-\ h\\:\\ 0\\.054854028175977905\ \(0\)\
\-\ hsv\\:\\ 0\\.045193617763545656\ \(0\)\
\-\ dna\\â\\€\\¦\\:\\ 0\\.04300252889739755\ \(0\)\
\-\ \\.\\.\\:\\ 0\\.0415611527417367\ \(0\)\
\-\ cu\\/mm\\:\\ 0\\.03962132313856855\ \(0\)\
\-\ ambient\\:\\ 0\\.03351028426785944\ \(0\)\
\-\ cistern\\:\\ 0\\.033417242794515654\ \(0\)\
\-\ acyclovir\\:\\ 0\\.03130547878618599\ \(0\)\
\-\ intensity\\:\\ 0\\.030133372452480985\ \(0\)\
\-\ lobe\\:\\ 0\\.02804055302345773\ \(0\)\
\-\ lobes\\:\\ 0\\.0275536274393924\ \(0\)\
\-\ signal\\:\\ 0\\.027476516222838764\ \(0\)\
\-\ aphasia\\:\\ 0\\.02625137180234806\ \(0\)\
\-\ csf\\:\\ 0\\.026110934281507407\ \(0\)\
\-\ t1wi\\:\\ 0\\.025659367621839436\ \(0\)\
\-\ \\:\\:\\ 0\\.024810910594917034\ \(0\)\
\-\ greater\\:\\ 0\\.02348572944636952\ \(0\)\
\-\ mg\\/dl\\:\\ 0\\.023454562140165985\ \(0\)\
\-\ encephalitis\\:\\ 0\\.02328032759088755\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.022949485657527743\ \(0\)\
\-\ effacement\\:\\ 0\\.022870166043519057\ \(0\)\
\-\ patchy\\:\\ 0\\.022348350826191406\ \(0\)\
\-\ effect\\:\\ 0\\.022138231120018868\ \(0\)\
\-\ detected\\:\\ 0\\.02200708941835282\ \(0\)\
\-\ 115\\.0\\:\\ 0\\.021501264448698775\ \(0\)\
\-\ 12\\-60\\:\\ 0\\.021501264448698775\ \(0\)\
\-\ colorless\\:\\ 0\\.021501264448698775\ \(0\)\
\-\ 259\\:\\ 0\\.021501264448698775\ \(0\)\
\-\ 0\\-1\\:\\ 0\\.021501264448698775\ \(0\)\
\-\ encephalitides\\:\\ 0\\.021501264448698775\ \(0\)\
\-\ consciousness\\:\\ 0\\.02116186150969898\ \(0\)\
\-\ left\\:\\ 0\\.020987676642576177\ \(0\)\
\-\ intravenous\\:\\ 0\\.020686865587624954\ \(0\)\
\-\ episode\\:\\ 0\\.020636833879492323\ \(0\)\
\-\ gray\\:\\ 0\\.0203940948084725\ \(0\)\
\-\ medial\\:\\ 0\\.019999752538463797\ \(0\)\
\-\ 40\\-70\\:\\ 0\\.019810661569284276\ \(0\)\
\-\ 0\\.0\\-5\\.0\\:\\ 0\\.019810661569284276\ \(0\)\
\-\ 40\\-80\\:\\ 0\\.019810661569284276\ \(0\)\
\-\ hsv\\-1\\:\\ 0\\.019810661569284276\ \(0\)\
\-\ 11\\.2\\:\\ 0\\.01882172228121558\ \(0\)\
\-\ neurosyphilis\\:\\ 0\\.01882172228121558\ \(0\)\
\-\ epilepticus\\:\\ 0\\.018120058689869774\ \(0\)\
\-\ mild\\:\\ 0\\.016465269175105882\ \(0\)\
\-\ 133\\:\\ 0\\.016429455810455275\ \(0\)\
\-\ matter\\:\\ 0\\.016412097416589257\ \(0\)\
\-\ than\\:\\ 0\\.016383284304280054\ \(0\)\
\-\ mono\\:\\ 0\\.015885203246274276\ \(0\)\
\-\ hypoattenuation\\:\\ 0\\.015885203246274276\ \(0\)\
\-\ insular\\:\\ 0\\.015885203246274276\ \(0\)\
\-\ pcr\\:\\ 0\\.01544051652238658\ \(0\)\
\-\ increased\\:\\ 0\\.015296230110729189\ \(0\)\
\-\ wbc\\:\\ 0\\.01519548707597957\ \(0\)\
\-\ bilateral\\:\\ 0\\.015174276068154469\ \(0\)\
\-\ peripheral\\:\\ 0\\.015082601570800571\ \(0\)\
\-\ 150\\:\\ 0\\.014738852931040772\ \(0\)\
\-\ evidenced\\:\\ 0\\.014194600366859773\ \(0\)\
\-\ sylvian\\:\\ 0\\.013853717580578899\ \(0\)\
\-\ herpes\\:\\ 0\\.013462637946249193\ \(0\)\
\-\ midbrain\\:\\ 0\\.01312568590117403\ \(0\)\
\-\ 99\\:\\ 0\\.013048250051626272\ \(0\)\
\-\ post\\-gadolinium\\:\\ 0\\.012973197225609799\ \(0\)\
\-\ t2wi\\:\\ 0\\.012503997487445273\ \(0\)\
\-\ products\\:\\ 0\\.012384997087032022\ \(0\)\
\-\ also\\:\\ 0\\.012326484831732815\ \(0\)\
\-\ loss\\:\\ 0\\.012099825231553363\ \(0\)\
\-\ receiving\\:\\ 0\\.01205931076355758\ \(0\)\
\-\ rbc\\:\\ 0\\.012009019819160662\ \(0\)\
\-\ low\\:\\ 0\\.011591063672519022\ \(0\)\
\-\ infiltrating\\:\\ 0\\.01131983208309966\ \(0\)\
\-\ one\\:\\ 0\\.011296250650295825\ \(0\)\
\-\ enhancement\\:\\ 0\\.011173115932307492\ \(0\)\
\-\ glucose\\:\\ 0\\.011139080931505218\ \(0\)\
\-\ dwi\\:\\ 0\\.011070371475488885\ \(0\)\
\-\ evidence\\:\\ 0\\.010928988211545745\ \(0\)\
\-\ protein\\:\\ 0\\.010694394207617522\ \(0\)\
\-\ subacute\\:\\ 0\\.010694394207617522\ \(0\)\
\-\ \\(\\:\\ 0\\.01057114721332479\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.010553370863986241\ \(0\)\
\-\ \\)\\:\\ 0\\.010442015006536173\ \(0\)\
\-\ color\\:\\ 0\\.010173481767866161\ \(0\)\
\-\ non\\-contrast\\:\\ 0\\.010173481767866161\ \(0\)\
\-\ asymmetric\\:\\ 0\\.010127022755742515\ \(0\)\
\-\ serum\\:\\ 0\\.010058952540822817\ \(0\)\
\-\ 1\\:\\ 0\\.009918665209559545\ \(0\)\
\-\ prognosis\\:\\ 0\\.009886206071143273\ \(0\)\
\-\ \\%\\:\\ 0\\.009723517235834183\ \(0\)\
\-\ ischemia\\:\\ 0\\.009686173993921725\ \(0\)\
\-\ restricted\\:\\ 0\\.009591991466780797\ \(0\)\
\-\ subtle\\:\\ 0\\.009573583648157913\ \(0\)\
\-\ flair\\:\\ 0\\.009555313717111187\ \(0\)\
\-\ 21\\:\\ 0\\.009431118374605682\ \(0\)\
\-\ poor\\:\\ 0\\.009379768596074384\ \(0\)\
\-\ diffusion\\:\\ 0\\.009329477651677468\ \(0\)\
\-\ there\\:\\ 0\\.009305235779012112\ \(0\)\
\-\ circumscribed\\:\\ 0\\.009263996554028228\ \(0\)\
\-\ \\,\\:\\ 0\\.009243758334736642\ \(0\)\
\-\ additionally\\:\\ 0\\.009033001550268184\ \(0\)\
\-\ foci\\:\\ 0\\.008946399871104987\ \(0\)\
\-\ enhanced\\:\\ 0\\.008918202743297486\ \(0\)\
\-\ suggest\\:\\ 0\\.008876509003396755\ \(0\)\
\-\ before\\:\\ 0\\.008822003396830909\ \(0\)\
\-\ right\\:\\ 0\\.008796406918150406\ \(0\)\
\-\ mass\\:\\ 0\\.008696056148396815\ \(0\)\
\-\ coronal\\:\\ 0\\.008678105004728577\ \(0\)\
\-\ appear\\:\\ 0\\.00853024007346898\ \(0\)\
\-\ presenting\\:\\ 0\\.00849463324561251\ \(0\)\
\-\ lymph\\:\\ 0\\.008413518070596699\ \(0\)\
\-\ clear\\:\\ 0\\.007706162471089379\ \(0\)\
\-\ involvement\\:\\ 0\\.007638874772262967\ \(0\)\
\-\ presence\\:\\ 0\\.007565330776724705\ \(0\)\
\-\ very\\:\\ 0\\.007565330776724705\ \(0\)\
\-\ status\\:\\ 0\\.0074398227345893984\ \(0\)\
\-\ new\\:\\ 0\\.007262897504391606\ \(0\)\
\-\ neoplasm\\:\\ 0\\.007097942868077874\ \(0\)\
\-\ inferior\\:\\ 0\\.007071503320387958\ \(0\)\
\-\ fever\\:\\ 0\\.007051860064760893\ \(0\)\
\-\ swelling\\:\\ 0\\.006943441131661299\ \(0\)\
\-\ density\\:\\ 0\\.006857637455755998\ \(0\)\
\-\ surrounding\\:\\ 0\\.006851622596011623\ \(0\)\
\-\ mr\\:\\ 0\\.006622437736454718\ \(0\)\
\-\ abscess\\:\\ 0\\.006589844497888456\ \(0\)\
\-\ onset\\:\\ 0\\.006579076160793049\ \(0\)\
\-\ frontal\\:\\ 0\\.006547053498739896\ \(0\)\
\-\ yo\\:\\ 0\\.006271589081226249\ \(0\)\
\-\ in\\:\\ 0\\.006166788733759828\ \(0\)\
\-\ \\.\\:\\ 0\\.006147480641247769\ \(0\)\
\-\ t2\\:\\ 0\\.005898996996952078\ \(0\)\
\-\ edema\\:\\ 0\\.005894935340076319\ \(0\)\
\-\ ct\\:\\ 0\\.0058307495287416725\ \(0\)\
\-\ secondary\\:\\ 0\\.005826902357338555\ \(0\)\
\-\ he\\:\\ 0\\.005815091078129316\ \(0\)\
\-\ shows\\:\\ 0\\.00573017975543629\ \(0\)\
\-\ blood\\:\\ 0\\.005688807493925121\ \(0\)\
\-\ presented\\:\\ 0\\.00568136008542051\ \(0\)\
\-\ is\\:\\ 0\\.005485763691558299\ \(0\)\
\-\ the\\:\\ 0\\.005395094037214665\ \(0\)\
\-\ of\\:\\ 0\\.004830645398940984\ \(0\)\
\-\ and\\:\\ 0\\.004829509909888788\ \(0\)\
\-\ other\\:\\ 0\\.004803996460249874\ \(0\)\
\-\ mri\\:\\ 0\\.004788477694913707\ \(0\)\
\-\ contrast\\:\\ 0\\.004665306553190013\ \(0\)\
\-\ demonstrates\\:\\ 0\\.004552734638178502\ \(0\)\
\-\ 2\\:\\ 0\\.004488059747586698\ \(0\)\
\-\ seen\\:\\ 0\\.0041186039391894885\ \(0\)\
\-\ within\\:\\ 0\\.003975930264356296\ \(0\)\
\-\ male\\:\\ 0\\.0037687939948474955\ \(0\)\
\-\ by\\:\\ 0\\.0034704168371826214\ \(0\)\
\-\ as\\:\\ 0\\.003152628063156409\ \(0\)\
\-\ not\\:\\ 0\\.0030117528579071593\ \(0\)\
\-\ are\\:\\ 0\\.002841155786657565\ \(0\)\
\-\ at\\:\\ 0\\.0028238125678820315\ \(0\)\
\-\ this\\:\\ 0\\.0023442371056442268\ \(0\)\
\-\ no\\:\\ 0\\.002098644270009273\ \(0\)\
\-\ patient\\:\\ 0\\.00208924861199119\ \(0\)\
\-\ to\\:\\ 0\\.002083259065575543\ \(0\)\
\-\ with\\:\\ 0\\.0017122562354618012\ \(0\)\
